A new study published in the journal Nucleic Acid Therapeutics reports on a novel therapeutic approach that targets key regions of the dengue virus genome vital for viral replication and thereby prevents the virus from reproducing in humans.
Pei-wen Xie, Yu Xie, Xiu-juan Zhang, Hai Huang, Li-na He, Xue-jun Wang, and Sheng-qi Wang, Beijing Institute of Radiation Medicine and Second Artillery General Hospital, Beijing, and Central South University, Changsha, China, identified multiple regions in the dengue virus genome that have maintained the same nucleic sequence over long periods of evolution. These highly conserved regions are ideal targets for antiviral drug development as they are unlikely to mutate and allow the virus to develop drug resistance.
AdvertisementIn the article Inhibition of Dengue Virus 2 Replication by Artificial MicroRNAs Targeting the Conserved Regions, the authors describe how they constructed artificial short strands of nucleic acids called microRNAs that specifically target these conserved sites in the dengue virus genome. Their experiments led to the identification of the most effective combinations of microRNAs capable of inhibiting the virus from replication in humans.
"The dengue virus is endemic in over 100 countries and spreading rapidly," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "In the absence of effective preventive measures, new treatments like those being pursued by Xie et al. are desperately needed."
P Hippo Pathway Could be Tapped for More Effective Cancer Treatments Man-Made Pollution Causes Two Million Deaths Every Year M
You May Also Like